CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Qiagen N.V. Company Snapshot
Qiagen N.V. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Qiagen N.V. with three other pharmaceutical manufacturers in Europe: Recordati Industria Chimica e Farmaceutica SpA of ITALY (2019 sales of 1.48 billion Euros [US$1.76 billion] of which 83% was Specialty & Primary care), Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag of HUNGARY (507.79 billion Hungarian Forints [US$1.67 billion] of which 78% was Pharmaceutical Manufacturing and Sale), and Swedish Orphan Biovitrum AB (publ) which is based in SWEDEN (14.25 billion Swedish Kronor [US$1.62 billion] of which 100% was Pharmaceuticals).

Sales Analysis. Qiagen N.V. reported sales of 1.37 billion Euro (US$1.62 billion) for the year ending December of 2019. This represents an increase of 7.1% versus 2018, when the company's sales were 1.27 billion Euro. Sales at Qiagen N.V. have increased during each of the previous five years (and since 2014, sales have increased a total of 34%). Sales of Consumables and Related Revenues saw an increase of 8.5% in 2019, from 1.12 billion Euro to 1.21 billion Euro. Not all segments of Qiagen N.V. experienced an increase in sales in 2019: sales of Instrumentation fell 2.6% to 154.13 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Qiagen N.V.
  Stock Performance Chart for Qiagen N.V.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 42.70
(Figures in Euros )
1 Week 2.1%   13 Weeks -3.8%  
4 Weeks 12.1%   52 Weeks 39.7%  
 
Qiagen N.V. Key Data:
  Ticker: QGEN Country: Netherlands
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 1,365,615,232
(Year Ending Jan 2020).
Employees: 5,096
  Currency: Euros Market Cap: 9,756,247,096
  Fiscal Yr Ends: December Shares Outstanding: 228,486,000
  Share Type: Aandeel Closely Held Shares: 14,133,925
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.